Herve Affagard, CEO and co-founder of MaaT Pharma and Jonathan Chriqui, Chief Business Officer, will attend the 2024 edition of HTID#6 by HealthTech For Care, dedicated to driving the future of healthcare innovation.
We’re eager to connect with other key European leaders, investors and share our progress in advancing innovative therapies for patients fighting cancer.
